Assignee
PERSONGEN BIOTHERAPEUTICS SUZHOU CO LTD
CN·1 granted patent·7 pending applications·23 citations·filing 2015–2022
Top patents by PatentIndex Score
8 records- 0188US10106609B2CD7 nanobodies, encoding sequence and use thereofPERSONGEN BIOTHERAPEUTICS SUZHOU CO LTD·Filed 2015·Granted Oct 23, 2018·23 cites·10 claims
- 0259US2025074997A1Development of novel upar single-domain antibodyPERSONGEN BIOTHERAPEUTICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0359US2025136695A1Development of novel pdl1 single-domain antibodyPERSONGEN BIOTHERAPEUTICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0455US2025186492A1Car-t cell targeting b7-h3 and application thereof in treatment of acute myeloid leukemiaPERSONGEN BIOTHERAPEUTICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0555US2025002583A1Human cd276-targeting monoclonal antibody and application thereofPERSONGEN BIOTHERAPEUTICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0655US2024016842A1Preparation method and application of cd7-car-t cellsPERSONGEN BIOTHERAPEUTICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0750US2023128800A1Cd7-car-t cell and preparation and application thereofPERSONGEN BIOTHERAPEUTICS SUZHOU CO LTD·Filed 2020·Application pending·0 cites
- 0849US2023159636A1Cd7 chimeric antigen receptor-modified nk-92mi cell and use thereofPERSONGEN BIOTHERAPEUTICS SUZHOU CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PERSONGEN BIOTHERAPEUTICS SUZHOU CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →